Secondary prevention of problems in health status in patients with COPD by early detection, motivational intervention to engage in treatment by the patient and by individualized treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24431

Enrollment

120

Registered

2009-06-08

Start date

2007-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD), Health Status, Quality of Life, Intervention, Patient-tailored treatment, gezondheidstoestand, kwaliteit van leven, interventie, zorg op maat

Interventions

Based on the indepent clinical interpretation of the PatientProfileChart by three professionals, patients are assigned to one of the following groups: 1. Patients with no clinically relevant problems

2. Patients with clinically relevant problems in health status (group II/III). Patients with clinically relevant problems in health status are randomized to a control group (group II: usual care as d

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis COPD according to GOLD-criteria.

Exclusion criteria

Exclusion criteria: 1. Not competent enough in understanding Dutch language; 2. Participation in pulmonary rehabilitation program within the previous six months.

Design outcomes

Primary

Measure	Time frame
1. Physiological Functioning: TLC%p predicted, RV% predicted, FEV1% predicted, BMI; 2. Symptoms: A. Physical Activity Rating Scale Dyspnoea; B. Global Dyspnoea Activity and Global Dyspnoea Burden; C. Dyspnoea Emotions Questionnaire; D. Frustration and Anxiety; E. Checklist Individual Strength; F. Fatigue. 3. Quality of Life: A. Beck Depression Inventory Primary Care; B. Satisfaction with Life Scale; C. Satisfaction Physical, Satisfaction Future, Satisfaction Spouse and Satisfaction Social. 4. Functional Impairment: A. Quality of Life for Respiratory Illness Questionnaires; B. General Activities; C. Sickness Impact Profile; D. Home Management and Ambulation. 5. The number of additional treatments in both groups.	—

Measure

Time frame

1. Physiological Functioning: TLC%p predicted, RV% predicted, FEV1% predicted, BMI; 2. Symptoms: A. Physical Activity Rating Scale Dyspnoea; B. Global Dyspnoea Activity and Global Dyspnoea Burden; C. Dyspnoea Emotions Questionnaire; D. Frustration and Anxiety; E. Checklist Individual Strength; F. Fatigue. 3. Quality of Life: A. Beck Depression Inventory Primary Care; B. Satisfaction with Life Scale; C. Satisfaction Physical, Satisfaction Future, Satisfaction Spouse and Satisfaction Social. 4. Functional Impairment: A. Quality of Life for Respiratory Illness Questionnaires; B. General Activities; C. Sickness Impact Profile; D. Home Management and Ambulation. 5. The number of additional treatments in both groups.

—

Secondary

Measure	Time frame
1. Smoking status; 2. Patient satisfaction with treatment; 3. Accuracy of diagnostic properties of the PatientProfileChart; 4. Sociodemographic variables (sex, age, education, personal situation, work situation); 5. Clinical variables (comorbidity, previous and current treatments, hospitalization).	—

Contacts

Public ContactLeonie Daudey

Postbus 66

l.daudey@mps.umcn.nl0031-24-6859558

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)